{"id":"https://openalex.org/W2168388707","doi":"https://doi.org/10.1517/13543780902729412","title":"S-1: a promising new oral fluoropyrimidine derivative","display_name":"S-1: a promising new oral fluoropyrimidine derivative","alternate_titles":[],"publication_year":2009,"publication_date":"2009-03-01","ids":{"openalex":"https://openalex.org/W2168388707","doi":"https://doi.org/10.1517/13543780902729412","mag":"2168388707","pmid":"https://pubmed.ncbi.nlm.nih.gov/19243284"},"language":"en","primary_location":{"id":"doi:10.1517/13543780902729412","doi":"https://doi.org/10.1517/13543780902729412","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543780902729412","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2168388707"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110323346","display_name":"M. W. Saif","orcid":"https://orcid.org/0000-0001-8154-957X","observed_orcids":["https://orcid.org/0000-0001-8154-957X"]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["GR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Muhammad Wasif Saif","raw_affiliation_strings":["Yale University School of Medicine, Division of Medical Oncology, 333 Cedar Street, FMP 116 New Haven, CT 06520, USA. wasif.saif@yale.edu","Athens Medical School, Oncology Unit, 3rd Department of Medicine, Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University School of Medicine, Division of Medical Oncology, 333 Cedar Street, FMP 116 New Haven, CT 06520, USA. wasif.saif@yale.edu","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"Athens Medical School, Oncology Unit, 3rd Department of Medicine, Athens, Greece","institution_ids":["https://openalex.org/I200777214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109951064","display_name":"Kostas Syrigos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["GR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kostas N Syrigos","raw_affiliation_strings":["Athens Medical School, Oncology Unit, 3rd Department of Medicine, Athens, Greece; Yale University School of Medicine, Division of Medical Oncology, 333 Cedar Street, FMP 116 New Haven, CT 06520, USA +1 203 737 1569; +1 203 785 3788; wasif.saif@yale.edu","Athens Medical School, Oncology Unit, 3rd Department of Medicine, Athens, Greece","Yale University School of Medicine, Division of Medical Oncology, 333 Cedar Street, FMP 116 New Haven, CT 06520, USA +1 203 737 1569"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Athens Medical School, Oncology Unit, 3rd Department of Medicine, Athens, Greece; Yale University School of Medicine, Division of Medical Oncology, 333 Cedar Street, FMP 116 New Haven, CT 06520, USA +1 203 737 1569; +1 203 785 3788; wasif.saif@yale.edu","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"Athens Medical School, Oncology Unit, 3rd Department of Medicine, Athens, Greece","institution_ids":["https://openalex.org/I200777214"]},{"raw_affiliation_string":"Yale University School of Medicine, Division of Medical Oncology, 333 Cedar Street, FMP 116 New Haven, CT 06520, USA +1 203 737 1569","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110273752","display_name":"Nikos A Katirtzoglou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nikos A Katirtzoglou","raw_affiliation_strings":["Yale University School of Medicine, Division of Medical Oncology, 333 Cedar Street, FMP 116 New Haven, CT 06520, USA +1 203 737 1569; +1 203 785 3788; wasif.saif@yale.edu","Yale University School of Medicine, Division of Medical Oncology, 333 Cedar Street, FMP 116 New Haven, CT 06520, USA +1 203 737 1569"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University School of Medicine, Division of Medical Oncology, 333 Cedar Street, FMP 116 New Haven, CT 06520, USA +1 203 737 1569; +1 203 785 3788; wasif.saif@yale.edu","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"Yale University School of Medicine, Division of Medical Oncology, 333 Cedar Street, FMP 116 New Haven, CT 06520, USA +1 203 737 1569","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8296,"has_fulltext":false,"cited_by_count":109,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.65812762,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"18","issue":"3","first_page":"335","last_page":"348"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.5264000296592712,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.5264000296592712,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.15809999406337738,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.12849999964237213,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/s-1","display_name":"S-1","score":0.9309999942779541},{"id":"https://openalex.org/keywords/oral-fluoropyrimidine","display_name":"oral fluoropyrimidine","score":0.7979999780654907},{"id":"https://openalex.org/keywords/tegafur","display_name":"tegafur","score":0.7710000276565552},{"id":"https://openalex.org/keywords/5-fluorouracil-prodrug","display_name":"5-fluorouracil prodrug","score":0.8980000019073486},{"id":"https://openalex.org/keywords/dihydropyrimidine-dehydrogenase-inhibition","display_name":"dihydropyrimidine dehydrogenase inhibition","score":0.9340000152587891},{"id":"https://openalex.org/keywords/potassium-oxonate","display_name":"potassium oxonate","score":0.9309999942779541},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.6480000019073486},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/head-and-neck-cancer","display_name":"head and neck cancer","score":0.9850000143051147},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.7770000100135803},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C111771559","wikidata":"https://www.wikidata.org/wiki/Q66295","display_name":"Derivative (finance)","level":2,"score":0.5751686096191406},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5057156085968018},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4806074798107147},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3713398575782776},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36681896448135376},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.34199637174606323},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3349919319152832},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.11904478073120117},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005641","descriptor_name":"Tegafur","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005641","descriptor_name":"Tegafur","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005641","descriptor_name":"Tegafur","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005641","descriptor_name":"Tegafur","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010094","descriptor_name":"Oxonic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010094","descriptor_name":"Oxonic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010094","descriptor_name":"Oxonic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010094","descriptor_name":"Oxonic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/13543780902729412","doi":"https://doi.org/10.1517/13543780902729412","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543780902729412","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:19243284","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19243284","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":100,"referenced_works":["https://openalex.org/W21933366","https://openalex.org/W31750938","https://openalex.org/W61003746","https://openalex.org/W73444543","https://openalex.org/W84051292","https://openalex.org/W156983979","https://openalex.org/W191332462","https://openalex.org/W367129424","https://openalex.org/W998140989","https://openalex.org/W1499419719","https://openalex.org/W1506696192","https://openalex.org/W1515227788","https://openalex.org/W1533708552","https://openalex.org/W1589227109","https://openalex.org/W1675957369","https://openalex.org/W1742102714","https://openalex.org/W1893512222","https://openalex.org/W1902766545","https://openalex.org/W1959630789","https://openalex.org/W1972107936","https://openalex.org/W1974449546","https://openalex.org/W1975809460","https://openalex.org/W1978106809","https://openalex.org/W1980253503","https://openalex.org/W1998103046","https://openalex.org/W1999445178","https://openalex.org/W2005627135","https://openalex.org/W2005829753","https://openalex.org/W2008575122","https://openalex.org/W2009778769","https://openalex.org/W2011447729","https://openalex.org/W2013537137","https://openalex.org/W2018619890","https://openalex.org/W2018782302","https://openalex.org/W2022932998","https://openalex.org/W2023241123","https://openalex.org/W2027678619","https://openalex.org/W2030023627","https://openalex.org/W2032032198","https://openalex.org/W2034135814","https://openalex.org/W2038787775","https://openalex.org/W2040401100","https://openalex.org/W2048300641","https://openalex.org/W2055983050","https://openalex.org/W2064792760","https://openalex.org/W2066312401","https://openalex.org/W2071418871","https://openalex.org/W2075876706","https://openalex.org/W2077734054","https://openalex.org/W2078000955","https://openalex.org/W2078292625","https://openalex.org/W2080806363","https://openalex.org/W2081084177","https://openalex.org/W2083922299","https://openalex.org/W2086737918","https://openalex.org/W2087362450","https://openalex.org/W2088231133","https://openalex.org/W2089310103","https://openalex.org/W2091190231","https://openalex.org/W2107890342","https://openalex.org/W2110617366","https://openalex.org/W2116815399","https://openalex.org/W2116957273","https://openalex.org/W2117452560","https://openalex.org/W2122866527","https://openalex.org/W2128328462","https://openalex.org/W2131926022","https://openalex.org/W2137991416","https://openalex.org/W2141121384","https://openalex.org/W2151824850","https://openalex.org/W2152256906","https://openalex.org/W2154767509","https://openalex.org/W2155185445","https://openalex.org/W2170726903","https://openalex.org/W2171075804","https://openalex.org/W2184708148","https://openalex.org/W2229238935","https://openalex.org/W2241507993","https://openalex.org/W2258953509","https://openalex.org/W2296169708","https://openalex.org/W2296894838","https://openalex.org/W2396149304","https://openalex.org/W2396646859","https://openalex.org/W2399701102","https://openalex.org/W2402110970","https://openalex.org/W2403423007","https://openalex.org/W2403523411","https://openalex.org/W2407051471","https://openalex.org/W2408970880","https://openalex.org/W2414621713","https://openalex.org/W2415335061","https://openalex.org/W2417932277","https://openalex.org/W2418803123","https://openalex.org/W2418827130","https://openalex.org/W2419532975","https://openalex.org/W2430807912","https://openalex.org/W2466607817","https://openalex.org/W2586483560","https://openalex.org/W3166083862","https://openalex.org/W4243012757"],"related_works":["https://openalex.org/W2430807912","https://openalex.org/W2027678619","https://openalex.org/W2117452560","https://openalex.org/W166961482","https://openalex.org/W2009938692","https://openalex.org/W2100642935","https://openalex.org/W2587941813","https://openalex.org/W2075707918","https://openalex.org/W2154767509","https://openalex.org/W2035456243"],"abstract_inverted_index":{"The":[0,84,280],"fluoropyrimidine":[1,130,173],"anticancer":[2],"agent":[3],"5-fluorouracil":[4],"(5-FU)":[5],"is":[6,26,90,212,276,290],"active":[7,213],"in":[8,102,115,135,194,236,285],"a":[9,33,74,195,209,334],"wide":[10],"range":[11],"of":[12,73,80,82,87,98,110,120,138,177,198,217,253,264,317,323,333],"solid":[13,325],"tumors,":[14],"particularly":[15],"gastric,":[16,218],"colorectal,":[17,219],"and":[18,20,32,52,113,117,122,159,184,190,221,227,239,267,273,278,301,304,327],"head":[19,220],"neck":[21],"cancers.":[22,229],"Whilst":[23],"infusional":[24],"5-FU":[25,60,66,88,121,139,179,303],"associated":[27],"with":[28,38,77,153,255,268,283],"higher":[29],"response":[30],"rates":[31],"favorable":[34],"safety":[35],"profile":[36],"compared":[37],"the":[39,50,70,78,95,103,111,136,171,178,215,246,251,262,286,305,315,321,331],"classical":[40],"i.v.":[41,300],"bolus":[42,302],"administration,":[43],"prolonged":[44],"infusions":[45],"can":[46],"be":[47,313,329],"inconvenient":[48],"for":[49,64,214,261,270,320],"patients,":[51],"catheter-related":[53],"problems":[54],"are":[55,233,242],"common":[56],"complications.":[57],"An":[58],"oral":[59,85,129,172,307,318],"formulation":[61],"would":[62],"allow":[63],"sustained":[65],"plasma":[67],"concentrations,":[68],"mimicking":[69],"pharmacokinetics":[71],"(PK)":[72],"continuous":[75,299],"infusion":[76],"addition":[79],"convenience":[81],"administration.":[83],"administration":[86],"itself":[89],"not":[91,296],"feasible":[92,277],"owing":[93],"to":[94,244,337],"high":[96],"activity":[97,281],"dihydropyrimidine":[99],"dehydrogenase":[100],"(DPD)":[101],"gut":[104],"wall,":[105],"which":[106,175],"causes":[107],"rapid":[108],"metabolism":[109],"drug":[112],"results":[114,241],"decreased":[116],"erratic":[118],"absorption":[119],"nonlinear":[123],"PK.":[124],"To":[125],"bypass":[126],"this":[127],"problem,":[128],"derivatives":[131],"were":[132],"developed":[133],"either":[134],"form":[137],"prodrugs":[140,158],"(i.e.,":[141,150,162],"tegafur,":[142],"doxifluridine":[143],"or":[144,146,155,165,259],"capecitabine),":[145],"as":[147,156,208],"enzyme":[148,160,186],"inhibitors":[149,161],"eniluracil)":[151],"administered":[152],"5-FU,":[154],"both":[157],"S-1,":[163,174,207],"UFT":[164],"BOF-A2).":[166],"This":[167],"review":[168],"focuses":[169],"on":[170,330],"consists":[176],"prodrug":[180],"tegafur":[181],"(ftorafur,":[182],"FT)":[183],"two":[185],"inhibitors,":[187],"CDHP":[188],"(5-chloro-2,4-dihydroxypyridine)":[189],"OXO":[191],"(potassium":[192],"oxonate),":[193],"molar":[196],"ratio":[197],"1(FT):0.4":[199],"(CDHP):1(OXO).":[200],"Phase":[201,230,247,287],"II":[202,248,288],"trials":[203,232],"have":[204],"demonstrated":[205],"that":[206],"single":[210],"agent,":[211],"treatment":[216,263,338],"neck,":[222],"breast,":[223],"non-small":[224,271],"cell":[225,272],"lung,":[226],"pancreatic":[228,274],"III":[231],"currently":[234],"underway":[235],"gastric":[237,265],"cancer":[238,266,275],"these":[240],"awaited":[243],"confirm":[245],"findings.":[249],"Furthermore,":[250],"combination":[252],"S-1":[254,284],"cisplatin":[256],"(CDDP),":[257],"irinotecan":[258],"docetaxel":[260],"CDDP":[269],"active.":[279],"observed":[282],"studies":[289],"at":[291],"least":[292],"equivalent":[293],"to,":[294],"if":[295],"better":[297],"than,":[298],"other":[306],"fluoropyrimidines.":[308],"Thus,":[309],"we":[310],"may":[311],"finally":[312],"seeing":[314],"realization":[316],"treatments":[319],"management":[322],"various":[324],"tumors":[326],"could":[328],"brink":[332],"new":[335],"approach":[336],"strategies.":[339]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2168388707","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
